AGFB Agfa-Gevaert NV

Annual General Meeting of Agfa-Gevaert NV - regulated information

Annual General Meeting of Agfa-Gevaert NV - regulated information

                                       

May 13, 2025 – 5.40 PM CET

Regulated information

Annual General Meeting of Agfa-Gevaert NV

Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET

At Agfa-Gevaert's Annual General Meeting, the 2024 financial statements, the allocation of the result, the remuneration report, the remuneration policy and the discharge of directors and statutory auditor were approved.

Furthermore, the shareholders rendered available all share premiums that can be rendered available without specific formalities, in order to allow the Board of Directors to use these share premiums to offset losses incurred.

PwC Bedrijfsrevisoren BV/PwC Réviseurs d’Entreprises SRL was appointed as statutory auditor charged with the assurance of the stand-alone and consolidated sustainability information of the Company. The shareholders also approved the fees for the assurance of this information.

About Agfa-Gevaert

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds three divisions: Radiology Solutions, HealthCare IT and Digital Print & Chemicals. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2024, the Group realized a turnover of 1,138 million euro.

Contact:

Viviane Dictus

Director Corporate Communications

tel. 4

e-mail:

Attachment



EN
13/05/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Wim Lewi
Guy Sips ... (+6)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi

Morning Notes : AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXF...

: AGS BB, AGFB BB, IVA FP, RET BB, TWEKA NA, VAN BB, NXFIL NA, IMCD NA

 PRESS RELEASE

The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, s...

The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film                                         Regulated information August 27, 2025 - 7:45 a.m. CET        The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film Group performance: Strong HealthCare IT performance and stable Digital Print & Chemicals performance not sufficiently offsetting the continued fast decline in medical filmAdjusted EBITDA decreased...

 PRESS RELEASE

De Agfa-Gevaert Groep in het tweede kwartaal van 2025: Sterke prestati...

De Agfa-Gevaert Groep in het tweede kwartaal van 2025: Sterke prestatie HealthCare IT, stabiele prestatie Digital Print & Chemicals – verdere achteruitgang medische film                                                         Gereglementeerde informatie 27 augustus 2025 - 7:45 uur CET                De Agfa-Gevaert Groep in het tweede kwartaal van 2025: Sterke prestatie HealthCare IT, stabiele prestatie Digital Print & Chemicals – verdere achteruitgang medische film Groepsprestatie: Sterke prestatie van HealthCare IT en stabiele prestatie van Digital Print & Chemicals volstaan niet om de ...

 PRESS RELEASE

Agfa-Gevaert NV tekent nieuwe doorlopende kredietfaciliteit - Geregle...

Agfa-Gevaert NV tekent nieuwe doorlopende kredietfaciliteit - Gereglementeerde informatie – Bevat voorwetenschap 1 augustus 2025 – 18u00 CET Gereglementeerde informatie – Bevat voorwetenschap Agfa-Gevaert NV tekent nieuwe doorlopende kredietfaciliteit Mortsel, België – 1 augustus 2025 – 18u00 CET Agfa-Gevaert NV heeft een nieuwe voor 3 jaar geldende doorlopende kredietfaciliteit getekend voor een bedrag van 180 miljoen euro. De nieuwe faciliteit loopt tot 1 augustus 2028. Deze nieuwe doorlopende kredietfaciliteit zal gebruikt worden voor werkkapitaal en algemene bedrijfsdoeleinden. Ze...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch